PRELUDE THERAPEUTICS INC's ticker is PRLD and the CUSIP is 74065P101. A total of 1 filers reported holding PRELUDE THERAPEUTICS INC in Q4 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $431 | -47.8% | 139,374 | -24.0% | 0.00% | 0.0% |
Q2 2023 | $825 | +4.6% | 183,300 | +32.3% | 0.00% | 0.0% |
Q1 2023 | $789 | -4.2% | 138,500 | +1.5% | 0.00% | 0.0% |
Q4 2022 | $824 | -99.9% | 136,500 | -4.8% | 0.00% | 0.0% |
Q3 2022 | $948,000 | +13.1% | 143,400 | -10.6% | 0.00% | 0.0% |
Q2 2022 | $838,000 | +202.5% | 160,486 | +300.2% | 0.00% | – |
Q1 2022 | $277,000 | -82.5% | 40,100 | -68.5% | 0.00% | -100.0% |
Q4 2021 | $1,584,000 | – | 127,200 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Orbimed Advisors | 15,594,877 | $1,115,813,000 | 9.76% |
Baker Brothers Advisors | 10,118,636 | $723,988,000 | 2.73% |
Rock Springs Capital Management LP | 360,363 | $25,784,000 | 0.55% |
HHLR ADVISORS, LTD. | 750,000 | $53,663,000 | 0.43% |
Old Well Partners, LLC | 3,450 | $247,000 | 0.13% |
SUVRETTA CAPITAL MANAGEMENT, LLC | 111,065 | $7,947,000 | 0.11% |
PERSONAL CFO SOLUTIONS, LLC | 4,500 | $322,000 | 0.08% |
ARS Investment Partners, LLC | 7,400 | $529,000 | 0.06% |
CAAS CAPITAL MANAGEMENT LP | 50,000 | $3,578,000 | 0.03% |
FMR LLC | 4,209,963 | $296,295,000 | 0.03% |